Outgrowth, proliferative speed and angiogenic capacity of Endothelial Colony Forming Cells (ECFC) correlate with disease severity and right ventricular (RV) adaptation in Pulmonary Arterial Hypertension (PAH) patients

J. Smits (Amsterdam, Netherlands), D. Tasev (Amsterdam, Netherlands), R. Szulcek (Amsterdam, Netherlands), S. Andersen (Aarhus, Denmark), S. Ringaard (Aarhus, Denmark), J. Hyldebradt (Aarhus, Denmark), A. Andersen (Aarhus, Denmark), A. Vonk-Noordegraaf (Amsterdam, Netherlands), P. Koolwijk (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands)

Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Session: Pathobiology of pulmonary hypertension
Session type: Poster Discussion
Number: 3934
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Smits (Amsterdam, Netherlands), D. Tasev (Amsterdam, Netherlands), R. Szulcek (Amsterdam, Netherlands), S. Andersen (Aarhus, Denmark), S. Ringaard (Aarhus, Denmark), J. Hyldebradt (Aarhus, Denmark), A. Andersen (Aarhus, Denmark), A. Vonk-Noordegraaf (Amsterdam, Netherlands), P. Koolwijk (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands). Outgrowth, proliferative speed and angiogenic capacity of Endothelial Colony Forming Cells (ECFC) correlate with disease severity and right ventricular (RV) adaptation in Pulmonary Arterial Hypertension (PAH) patients. 3934

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014

Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014


MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Obligatory role of MEK/ERK/RSK90 in the mitogenic responses of human pulmonary artery smooth muscle cells
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Neutrophil- to-lymphocyte ratio as a prognostic parameter in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Afterload reduction governs improvement in RV systolic function and ventriculo-arterial adaptation in patients with pulmonary arterial hypertension (PAH) undergoing rapid dose escalation of treprostinil
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Treprostinil prodrugs for pulmonary arterial hypertension evaluated in cAMP profiling studies in live CHO-K1 cells
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Measurement of cardiac troponin identifies patients with moderate to large pulmonary emboli and right ventricular strain
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Arterial hypertension (AH) and endothelial function (EF) in patients with COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Right ventricular contractile reserve is markedly impaired and correlates with exercise capacity in pulmonary arterial hypertension: A dobutamine stress echocardiography study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014